Equistar Veterinary Services Limited 09208172 false 2020-12-01 2021-11-30 2021-11-30 The principal activity of the company is provision of veterinary activities. Digita Accounts Production Advanced 6.30.9574.0 true false 09208172 2020-12-01 2021-11-30 09208172 2021-11-30 09208172 bus:Director1 1 2021-11-30 09208172 core:RetainedEarningsAccumulatedLosses 2021-11-30 09208172 core:ShareCapital 2021-11-30 09208172 core:CurrentFinancialInstruments core:WithinOneYear 2021-11-30 09208172 core:Non-currentFinancialInstruments 2021-11-30 09208172 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2021-11-30 09208172 bus:SmallEntities 2020-12-01 2021-11-30 09208172 bus:AuditExemptWithAccountantsReport 2020-12-01 2021-11-30 09208172 bus:FullAccounts 2020-12-01 2021-11-30 09208172 bus:SmallCompaniesRegimeForAccounts 2020-12-01 2021-11-30 09208172 bus:RegisteredOffice 2020-12-01 2021-11-30 09208172 bus:Director1 2020-12-01 2021-11-30 09208172 bus:Director1 1 2020-12-01 2021-11-30 09208172 bus:PrivateLimitedCompanyLtd 2020-12-01 2021-11-30 09208172 core:FurnitureFittings 2020-12-01 2021-11-30 09208172 core:PlantMachinery 2020-12-01 2021-11-30 09208172 countries:England 2020-12-01 2021-11-30 09208172 2020-11-30 09208172 bus:Director1 1 2020-11-30 09208172 2019-12-01 2020-11-30 09208172 2020-11-30 09208172 bus:Director1 1 2020-11-30 09208172 core:RetainedEarningsAccumulatedLosses 2020-11-30 09208172 core:ShareCapital 2020-11-30 09208172 core:CurrentFinancialInstruments core:WithinOneYear 2020-11-30 09208172 core:Non-currentFinancialInstruments 2020-11-30 09208172 bus:Director1 1 2019-12-01 2020-11-30 09208172 bus:Director1 1 2019-11-30 iso4217:GBP xbrli:pure

Registration number: 09208172

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 November 2021

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

(Registration number: 09208172)
Abridged Balance Sheet as at 30 November 2021

Note

2021
£

2020
£

Fixed assets

 

Tangible assets

4

37,086

43,922

Investments

5

1

1

 

37,087

43,923

Current assets

 

Stocks

17,375

15,305

Debtors

85,949

38,646

Cash at bank and in hand

 

231,426

146,776

 

334,750

200,727

Creditors: Amounts falling due within one year

(77,726)

(12,019)

Net current assets

 

257,024

188,708

Total assets less current liabilities

 

294,111

232,631

Provisions for liabilities

1,973

5,838

Net assets

 

296,084

238,469

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

295,984

238,369

Total equity

 

296,084

238,469

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

(Registration number: 09208172)
Abridged Balance Sheet as at 30 November 2021

For the financial year ending 30 November 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 20 July 2022
 


 

Mr C Pinkham

Director

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 November 2021

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Home Farm Offices
Home Farm Road
Wilton
Salisbury
SP2 8PJ

These financial statements were authorised for issue by the director on 20 July 2022.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover represents the amounts, excluding value added tax, derived from the provision of goods and services to customers during the year.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% reducing balance

Fixtures and fittings

15% reducing balance

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 November 2021

Investments

Investments in equity shares where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in the profit or loss account. Investments in equity shares where fair value cannot be measured reliably are measured at cost less impairment.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 3 (2020 - 2).

4

Tangible assets

Total
£

Cost or valuation

At 1 December 2020

70,433

Additions

1,954

At 30 November 2021

72,387

Depreciation

At 1 December 2020

26,511

Charge for the year

8,790

At 30 November 2021

35,301

Carrying amount

At 30 November 2021

37,086

At 30 November 2020

43,922

 

Equistar Veterinary Services Limited

trading as BioTe Veterinary Laboratories

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 November 2021

5

Investments

Total
£

Cost or valuation

Additions

1

Provision

Carrying amount

At 30 November 2021

1

At 30 November 2020

1

6

Related party transactions

Transactions with directors

2021

At 1 December 2020
£

Repayments by director
£

At 30 November 2021
£

Mr C Pinkham

Director's advances and credits - repayable on demand.

1,871

(1,871)

-

       
     

 

2020

At 1 December 2019
£

Advances to directors
£

At 30 November 2020
£

Mr C Pinkham

Director's advances and credits - repayable on demand.

-

1,871

1,871